Cancer Moonshot℠ – Funding Opportunities

The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.

Open Funding Opportunity Announcements (FOAs)
BRP Recommendation Title Announcement Number Receipt Date
Therapeutic Target Identification to Overcome Resistance Notice of Special Interest: Administrative Supplements to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN) NOT-CA-19-032 07/01/2019
New Enabling Technologies Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed) PA-19-174 03/28/2019
Cancer Immunotherapy Translational Science Network Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-17-245 Multiple
Cancer Immunotherapy Translational Science Network Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) PAR-17-244 Multiple
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R21) PAR-16-229 Multiple
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R01) PAR-16-228 Multiple
Drivers of Childhood Cancers Gene Fusions in Pediatric Sarcomas (R21) PA-16-252 Multiple
Drivers of Childhood Cancers Gene Fusions in Pediatric Sarcomas (R01) PA-16-251 Multiple
Generation of Human Tumor Atlases Emerging Questions in Cancer Systems Biology (U01) PAR-16-131 Multiple
Cancer Immunotherapy Translational Science Network Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed) RFA-CA-19-044 04/25/2019
Cancer Immunotherapy Translational Science Network Notice of Special Interest: Administrative Supplements for Activities to Promote Human Immune-Representing Oncology Models NOT-CA-19-028 06/03/2019
Symptom Management Research Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors  RFA-CA-19-033 01/03/2020
  • Updated: March 11, 2019

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ – Funding Opportunities was originally published by the National Cancer Institute.”

We welcome your comments on this post. All comments must follow our comment policy.